Hearing Loss, Sensorineural Clinical Trial
Official title:
The Effect of Inhaled Hydrogen on the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
Idiopathic sudden sensorineural hearing loss (ISSHL) is defined according to American Academy of Otolaryngology as a hearing loss of at least 30 decibel over 3 contiguous test frequencies occurring within a 72h period. It affects 5 to 20 people per 100,000 annually and is characterized by sudden-onset, generally unilateral, sensorineural hearing loss. Its cause is idiopathic in most of the patients; however, vascular disorders have been proposed as the final common pathway. Recent studies have reported that the impaired microvascular perfusion occurring during an ischemic event may be related to oxidative stress which may be synergistically responsible for endothelial damage, especially in terminal microvascular systems. Hydrogen, which serves as a free radical scavenger and can reduce the strong oxidants, is found as a therapeutic gas in cochlea in recent studies. Both antioxidant and anti-inflammatory effects have been seen with hydrogen administration in animal models. Since cisplatinum toxicity and acoustic trauma both involve oxidative stress to the cochlea, hydrogen may prove useful in these conditions. The efficacy and safety of hydrogen inhalation are also proved in clinical studies. Given the theories mentioned above, the purpose of our study is to use inhaled hydrogen as an adjuvant therapy for treating idiopathic sudden sensorineural hearing loss. The systemic inflammation status and oxidative stress will be monitored. Both subjective and objective efficacy after treatment will be assessed.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04281953 -
Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
|
||
| Not yet recruiting |
NCT05973669 -
MED-EL Remote Care Multi-Center Feasibility Study
|
N/A | |
| Completed |
NCT04601909 -
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
|
Phase 1 | |
| Active, not recruiting |
NCT04479761 -
Sensory Integration of Auditory and Visual Cues in Diverse Contexts
|
N/A | |
| Recruiting |
NCT05043207 -
A Study Protocol for the Validation of UAud in a Clinical Setting.
|
N/A | |
| Recruiting |
NCT04066270 -
Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
|
||
| Recruiting |
NCT04070937 -
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
|
||
| Completed |
NCT03512951 -
Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception
|
N/A | |
| Completed |
NCT05855005 -
Direct-to-Consumer Hearing Aids and Listening Effort
|
N/A | |
| Recruiting |
NCT05599165 -
Speech Perception in Bimodal Hearing
|
N/A | |
| Completed |
NCT05101083 -
Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
|
N/A | |
| Completed |
NCT05521308 -
Investigating Hearing Aid Frequency Response Curves
|
N/A | |
| Completed |
NCT05072457 -
Benefit of Assistive Listening Device for Lateralization
|
N/A | |
| Recruiting |
NCT05776459 -
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
|
Phase 2 | |
| Completed |
NCT05086276 -
FX-322 in Adults With Acquired Sensorineural Hearing Loss
|
Phase 2 | |
| Recruiting |
NCT06058767 -
Preschool Hearing Screening
|
N/A | |
| Completed |
NCT05180630 -
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
|
N/A | |
| Completed |
NCT03613909 -
Acceptance of the CP950 Sound Processor
|
N/A | |
| Active, not recruiting |
NCT03352154 -
Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants
|
N/A | |
| Completed |
NCT04629664 -
FX-322 in Adults With Severe Sensorineural Hearing Loss
|
Phase 1 |